| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/01/2007 | EP1434857B1 Method for production of recombinant proteins in eukaryote cells |
| 08/01/2007 | EP1432819B1 Method for determining cell cycle position |
| 08/01/2007 | EP1390754B1 Method and composition for skin grafts |
| 08/01/2007 | EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 08/01/2007 | EP1344821B1 Novel aggrecanase |
| 08/01/2007 | EP1287134B1 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 08/01/2007 | EP1185615B1 Recombinant influenza viruses for vaccines and gene therapy |
| 08/01/2007 | EP1165749B1 Method for preparing porous, biodegradable and biocompatible, polymeric scaffolds for tissue engineering |
| 08/01/2007 | EP1141293B1 Vascular endothelial growth factor-x |
| 08/01/2007 | EP1137761B1 Cutinase variants |
| 08/01/2007 | EP1082410B1 Human cd45+ and/or fibroblast + mesenchymal stem cells |
| 08/01/2007 | EP0695347B1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 08/01/2007 | CN1329733C Article handling system and method |
| 08/01/2007 | CN1329517C Shenzhen No.5 flameray gerbera transgene technology |
| 08/01/2007 | CN1329516C Modification of polysaccharide containing materials |
| 08/01/2007 | CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 08/01/2007 | CN1329507C Oriental fir tissue culture quick propagation technology and basic culture medium |
| 08/01/2007 | CN1329501C Bioreactor system and method |
| 08/01/2007 | CN1329078C Agents promoting proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |
| 08/01/2007 | CN101010587A Method of separating small hepatocytes by using specific antibody |
| 08/01/2007 | CN101010427A Anti-A33 antibody |
| 08/01/2007 | CN101010097A Hai-1 and hai-2 in cancer therapy |
| 08/01/2007 | CN101010086A Ceramide derivatives as modulators of immunity and autoimmunity |
| 08/01/2007 | CN101008016A Method for providing high expression karyon for transgenic clone animal |
| 08/01/2007 | CN101008004A Use of liver cell line QSG-7701 for infecting hepatitis B virus |
| 08/01/2007 | CN101008003A Pancreatic carcinoma cell lines with highly metastatic potential in the liver |
| 08/01/2007 | CN101008002A Use of Activin A in human embryo stem cell trophoblast-free cell culture |
| 08/01/2007 | CN101007999A Permeable and visible tri-dimensional cell culture system and its uses in tissue and newborn organ culture |
| 08/01/2007 | CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007847A Human horny cell growth factor-2 mutant and its preparation method |
| 08/01/2007 | CN101007835A Nucleic acid molecule RTN4BSR5 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007834A Nucleic acid molecule RTN4BSR4 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007833A Nucleic acid molecule RTN4BSR3 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007832A Nucleic acid molecule RTN4BSR2 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007831A Nucleic acid molecule RTN4BSR1and its application in preparing anticancer medicine |
| 08/01/2007 | CN101006768A Agrobacterium-mediated Sophora japonica transgenic and tissue-culturing rapid propagation method |
| 07/31/2007 | US7250561 Regulatory elements necessary for its transcription in plants and a coding sequence encoding an enzyme, hydroxyphenyl pyruvate dioxygenase, conferring on plants the tolerance to a herbicide |
| 07/31/2007 | US7250558 Disease resistance factors |
| 07/31/2007 | US7250557 Plastidic phosphoglucomutase genes |
| 07/31/2007 | US7250551 Inhibiting amyloid precursor protein phosphorylation; using kinase inhibitors; reducing, preventing and/or reversing Alzheimer's symptoms; transgenic mice, cell lines, assays |
| 07/31/2007 | US7250504 Class II human histone deacetylases, and uses related thereto |
| 07/31/2007 | US7250501 Bacillus crystal protein having improved insecticidal activity; transgenic plant; polynucleotide segment having a sequence region that encodes an insecticidal hybrid delta-endotoxin protein |
| 07/31/2007 | US7250495 PRO20044 polypeptides |
| 07/31/2007 | US7250494 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
| 07/31/2007 | US7250493 FC fusion proteins of human erythropoietin with increased biological activities |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
| 07/31/2007 | US7250405 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 07/31/2007 | US7250400 Can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition. |
| 07/31/2007 | US7250294 Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
| 07/31/2007 | US7250293 Complementing cell lines |
| 07/31/2007 | US7250292 Hypertonic reduction of chilling injury |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250284 Destabilized bioluminescent proteins |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250282 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250278 α-keto acid reductase, method for producing the same, and method for producing optically active α-hydroxy acids using the same |
| 07/31/2007 | US7250275 LIF has a differentiation prevention function for a chicken differentiable cell such as a chicken's embryonic stem cell or embryonic reproductive cell, effective as an anti-differentiator while the chicken differentiable cell is being cultured |
| 07/31/2007 | US7250263 Methods and compositions for identifying receptor effectors |
| 07/31/2007 | US7250262 For the diagnosis and treatment of patients with disorders including anemias |
| 07/31/2007 | US7250256 Its expression products can be used to provide reagents and methods for detecting neoplasia |
| 07/31/2007 | US7250255 Genes with ES cell-specific expression |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250173 helminths obtained from preparatory animals raised in a specific human pathogen-free environment used to treat an excessive immune response including an aberrant/enhanced Th1 response, e.g., Crohn's disease and ulcerative colitis |
| 07/31/2007 | US7250169 Anti-tumor activity of Ea-4-peptide of pro-IGF-1 |
| 07/31/2007 | US7250167 Monoclonal antibody for use in increasing kidney allograft suvival and as immunosuppressant; prevention of graft versus host disease |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | CA2288823C Chemical cleaning of biological material |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/31/2007 | CA1341537C Production of pluripotent granulocyte colony-stimulating factor |
| 07/26/2007 | WO2007084985A1 Composition and method to increase mammalian sperm function |
| 07/26/2007 | WO2007084730A2 Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture |
| 07/26/2007 | WO2007084678A2 Human liver cell line |
| 07/26/2007 | WO2007084585A2 Non-human primate embryonic stem and germ cells: methods of use and methods of making same |
| 07/26/2007 | WO2007084487A2 Pericytes for use as stem cells |
| 07/26/2007 | WO2007084486A2 Animal model for assessing copd-related diseases |
| 07/26/2007 | WO2007084105A2 Modulation of fc gamma receptors for optimizing immunotherapy |
| 07/26/2007 | WO2007083759A1 Bone destruction inhibitor comprising anti-ccl20 antibody |
| 07/26/2007 | WO2007083504A1 Scaffold-free self-organized 3d synthetic tissue |
| 07/26/2007 | WO2007083344A1 Method for culturing and detaching cells adhering to surfaces |
| 07/26/2007 | WO2007083093A1 Enrichment of cells |
| 07/26/2007 | WO2007082963A1 Human embryo stem-cell lines and methods for using same |
| 07/26/2007 | WO2007067460A3 Manipulation of biological species using magnetic field modulators |
| 07/26/2007 | WO2007065957A3 Methods for generating antigen-specific effector t cells |
| 07/26/2007 | WO2007056304A3 Mutated forms of ny-eso-1 produced in yeast and uses thereof |
| 07/26/2007 | WO2007051836A3 Compositions for treating dermatological and neurological disorders |
| 07/26/2007 | WO2007048813A3 Tissue engineering using pure populations of isolated non-embryoblastic fetal cells |
| 07/26/2007 | WO2007047718A3 Generation and use of vasculogenic tumors |
| 07/26/2007 | WO2007047578A3 Cell display of antibody libraries |
| 07/26/2007 | WO2007045691A3 Renal carcinoma cell line and use thereof |
| 07/26/2007 | WO2007036291A3 Improved cell culture medium |
| 07/26/2007 | WO2007030469A3 Transplantable cell growth niche and related compositions and methods |
| 07/26/2007 | WO2007024290A3 Nanoscale neuromodulating platform for retina neuron activation apparatus and method |
| 07/26/2007 | WO2007014134A3 Tandem cardiac pacemaker system |
| 07/26/2007 | WO2007008309A3 Stem and progenitor cell expansion by evi, evi-like genes and setbp1 |
| 07/26/2007 | WO2006128131A3 Co-grafts for treating parkinson's disease |
| 07/26/2007 | WO2006113861A3 Mammalian expression systems |
| 07/26/2007 | WO2006113743A3 Compositions and methods for rna interference with sialidase expression and uses thereof |